BR100 Increased By (0.82%)
BR30 Increased By (0.64%)
KSE100 Increased By (0.67%)
KSE30 Increased By (0.68%)
AGHA 7.80 Increased By ▲ 0.05 (0.65%)
BECO 5.19 No Change ▼ 0.00 (0%)
BML 57.93 Decreased By ▼ -0.73 (-1.24%)
BOP 34.25 Increased By ▲ 0.56 (1.66%)
CNERGY 10.90 Increased By ▲ 0.29 (2.73%)
CSIL 5.43 Increased By ▲ 0.13 (2.45%)
FCCL 54.63 Increased By ▲ 0.89 (1.66%)
FFL 16.74 Increased By ▲ 0.28 (1.7%)
FNEL 1.24 Increased By ▲ 0.02 (1.64%)
KEL 7.42 Increased By ▲ 0.14 (1.92%)
KOSM 5.78 Increased By ▲ 0.14 (2.48%)
LOTCHEM 29.78 Increased By ▲ 0.13 (0.44%)
MLCF 95.63 Decreased By ▼ -0.73 (-0.76%)
NBP 204.75 Increased By ▲ 1.22 (0.6%)
NCPL 57.66 Increased By ▲ 0.81 (1.42%)
NPL 69.30 Increased By ▲ 1.99 (2.96%)
OGDC 318.22 No Change ▼ 0.00 (0%)
PACE 10.81 Increased By ▲ 0.18 (1.69%)
PAEL 43.10 Increased By ▲ 1.33 (3.18%)
PIBTL 16.86 Increased By ▲ 0.05 (0.3%)
PPL 220.99 Increased By ▲ 0.82 (0.37%)
PRL 51.75 Increased By ▲ 2.70 (5.5%)
PTC 71.39 Increased By ▲ 1.38 (1.97%)
SSGC 29.20 Increased By ▲ 0.06 (0.21%)
TBL 9.88 Increased By ▲ 0.11 (1.13%)
TELE 8.86 Increased By ▲ 0.04 (0.45%)
TPL 17.80 Increased By ▲ 0.63 (3.67%)
TPLP 12.91 Increased By ▲ 0.40 (3.2%)
TREET 22.81 Increased By ▲ 0.22 (0.97%)
TRG 60.00 Decreased By ▼ -0.22 (-0.37%)
World

Germany to recommend AstraZeneca jab for over-65s: Merkel

  • Germany had previously said it lacked sufficient data to greenlight the jab for those over 65, but Merkel said that had changed thanks to recent encouraging studies.
Published Updated
By

BERLIN: Germany will soon authorise the AstraZeneca/Oxford vaccine against Covid for people over the age of 65, Chancellor Angela Merkel said Wednesday.

"The (German) vaccine commission, whose recommendations we are happy to follow, will authorise AstraZeneca for older age groups," she told reporters after talks with regional leaders on the next pandemic steps.

Germany had previously said it lacked sufficient data to greenlight the jab for those over 65, but Merkel said that had changed thanks to recent encouraging studies.

Comments

Comments are closed for this article.